Diagnos Laboratorium Utama Tbk. vs H.M. Sampoerna Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 6.3K 24h volume), while H.M. Sampoerna Tbk. trades at Rp730 (market cap 84.91T, 5.01M 24h volume). The key difference: H.M. Sampoerna Tbk. is far larger — about 266.2× Diagnos Laboratorium Utama Tbk.'s market cap, and H.M. Sampoerna Tbk. is more actively traded (5.01M versus 6.3K). Which is the better fit depends on your goals.
| DGNS | HMSP | |
|---|---|---|
Market Cap | 319B | 84.91T |
Volume | 6.3K | 5.01M |
Lot | 63 | 50.06K |
Turnover | 1.44M | 3.67B |
Average Price | 228.76 | 733.25 |
Value | 1.44M | 3.67B |
Indicative Equilibrium Price | 232 | 730 |
Indicative Equilibrium Volume | 200 | 6.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.
Read more on HMSP →